Tokyo, Mar 26 (UNI) Japanese drugmaker Kobayashi Pharmaceutical on Tuesday disclosed that one person has died after taking their supplement product containing "beni-koji," or red yeast rice, raising concerns about potential health hazards associated with the ingredient.